OPK
Price
$1.55
Change
-$0.02 (-1.27%)
Updated
Apr 4 closing price
Capitalization
920.03M
37 days until earnings call
TDSGF
Price
$0.06
Change
-$0.00 (-0.00%)
Updated
Apr 4 closing price
Capitalization
13.15M
Ad is loading...

OPK vs TDSGF

Header iconOPK vs TDSGF Comparison
Open Charts OPK vs TDSGFBanner chart's image
OPKO Health
Price$1.55
Change-$0.02 (-1.27%)
Volume$4.46M
Capitalization920.03M
Telo Genomics
Price$0.06
Change-$0.00 (-0.00%)
Volume$200
Capitalization13.15M
OPK vs TDSGF Comparison Chart
Loading...
OPK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
OPK vs. TDSGF commentary
Apr 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OPK is a StrongBuy and TDSGF is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 07, 2025
Stock price -- (OPK: $1.55 vs. TDSGF: $0.06)
Brand notoriety: OPK and TDSGF are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: OPK: 80% vs. TDSGF: 2%
Market capitalization -- OPK: $920.03M vs. TDSGF: $13.15M
OPK [@Medical Specialties] is valued at $920.03M. TDSGF’s [@Medical Specialties] market capitalization is $13.15M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OPK’s FA Score shows that 0 FA rating(s) are green whileTDSGF’s FA Score has 0 green FA rating(s).

  • OPK’s FA Score: 0 green, 5 red.
  • TDSGF’s FA Score: 0 green, 5 red.
According to our system of comparison, TDSGF is a better buy in the long-term than OPK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OPK’s TA Score shows that 4 TA indicator(s) are bullish.

  • OPK’s TA Score: 4 bullish, 5 bearish.

Price Growth

OPK (@Medical Specialties) experienced а -8.82% price change this week, while TDSGF (@Medical Specialties) price change was +5.62% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -6.38%. For the same industry, the average monthly price growth was -2.87%, and the average quarterly price growth was -1.88%.

Reported Earning Dates

OPK is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Medical Specialties (-6.38% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OPK($920M) has a higher market cap than TDSGF($13.2M). OPK YTD gains are higher at: 5.442 vs. TDSGF (-30.268). TDSGF has higher annual earnings (EBITDA): -2.59M vs. OPK (-65.52M). OPK has more cash in the bank: 95.9M vs. TDSGF (721K). TDSGF has less debt than OPK: TDSGF (40K) vs OPK (327M). OPK has higher revenues than TDSGF: OPK (863M) vs TDSGF (0).
OPKTDSGFOPK / TDSGF
Capitalization920M13.2M6,970%
EBITDA-65.52M-2.59M2,534%
Gain YTD5.442-30.268-18%
P/E Ratio26.11N/A-
Revenue863M0-
Total Cash95.9M721K13,301%
Total Debt327M40K817,500%
FUNDAMENTALS RATINGS
OPK vs TDSGF: Fundamental Ratings
OPK
TDSGF
OUTLOOK RATING
1..100
5350
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
45
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9096
PRICE GROWTH RATING
1..100
5689
P/E GROWTH RATING
1..100
97100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TDSGF's Valuation (45) in the null industry is in the same range as OPK (68) in the Biotechnology industry. This means that TDSGF’s stock grew similarly to OPK’s over the last 12 months.

TDSGF's Profit vs Risk Rating (100) in the null industry is in the same range as OPK (100) in the Biotechnology industry. This means that TDSGF’s stock grew similarly to OPK’s over the last 12 months.

OPK's SMR Rating (90) in the Biotechnology industry is in the same range as TDSGF (96) in the null industry. This means that OPK’s stock grew similarly to TDSGF’s over the last 12 months.

OPK's Price Growth Rating (56) in the Biotechnology industry is somewhat better than the same rating for TDSGF (89) in the null industry. This means that OPK’s stock grew somewhat faster than TDSGF’s over the last 12 months.

OPK's P/E Growth Rating (97) in the Biotechnology industry is in the same range as TDSGF (100) in the null industry. This means that OPK’s stock grew similarly to TDSGF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
OPK
RSI
ODDS (%)
Bullish Trend 3 days ago
80%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
87%
Momentum
ODDS (%)
Bearish Trend 3 days ago
84%
MACD
ODDS (%)
Bearish Trend 3 days ago
79%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
77%
Advances
ODDS (%)
Bullish Trend 21 days ago
76%
Declines
ODDS (%)
Bearish Trend 3 days ago
79%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
74%
Aroon
ODDS (%)
Bearish Trend 3 days ago
82%
View a ticker or compare two or three
Ad is loading...
OPK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RMCFX8.30-0.32
-3.71%
Royce Micro-Cap Svc
ACERX9.40-0.39
-3.98%
Invesco Equity and Income C
IICHX9.75-0.57
-5.52%
AMF Large Cap Equity H
RIVGX16.28-1.01
-5.84%
American Funds International Vntg R-6
REVCX10.99-0.76
-6.47%
Columbia Global Value C

OPK and

Correlation & Price change

A.I.dvisor indicates that over the last year, OPK has been loosely correlated with RVTY. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if OPK jumps, then RVTY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OPK
1D Price
Change %
OPK100%
-1.27%
RVTY - OPK
43%
Loosely correlated
-5.87%
XAIR - OPK
35%
Loosely correlated
-1.55%
ICUI - OPK
31%
Poorly correlated
-1.59%
FNA - OPK
28%
Poorly correlated
-0.15%
RDNT - OPK
28%
Poorly correlated
-1.64%
More

TDSGF and

Correlation & Price change

A.I.dvisor tells us that TDSGF and OPK have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TDSGF and OPK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TDSGF
1D Price
Change %
TDSGF100%
+0.74%
OPK - TDSGF
24%
Poorly correlated
-1.27%
PRPO - TDSGF
22%
Poorly correlated
+2.33%
EDTXF - TDSGF
20%
Poorly correlated
-2.03%
USAQ - TDSGF
10%
Poorly correlated
N/A
UEEC - TDSGF
6%
Poorly correlated
-1.11%
More